Het AZ Sint-Lucas is een modern en sociaal algemeen ziekenhuis in de Belgische stad Gent. Het ziekenhuis is gevestigd net ten noorden van de stadskern op een steenworp van het Gravensteen. Er zijn ook medische centra in Lochristi, Zelzate en Aalter.

During the past decade, AZ Sint-Lucas conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 24 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 19 clinical trials were completed. i.e. 59.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Sint-Lucas" #1 sponsor was "University Hospital, Ghent" with 13 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Boston Scientific Corporation" with 6 trials sponsored, "Pfizer" with 6 trials sponsored and "Amgen" with 6 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Sint-Lucas" #1 collaborator was "University Ghent" with 7 trials as a collaborator, "KU Leuven" with 5 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Takeda" with 3 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "AZ Sint-Lucas" are "Breast Cancer" (6 trials), "Crohn Disease" (6 trials), "Psoriasis Vulgaris" (6 trials), "Ulcerative Colitis" (6 trials) and "Prostate Cancer" (5 trials). Many other conditions were trialed in "AZ Sint-Lucas" in a lesser frequency.

Most popular intervention types in "AZ Sint-Lucas" are "Drug" (59 trials), "Other" (14 trials), "Device" (10 trials), "Procedure" (9 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Etrasimod" (5 trials), "Paclitaxel" (5 trials), "Venapuncture" (5 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "AZ Sint-Lucas" are 82 trials for "All" genders, 7 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "AZ Sint-Lucas". undefined are not yet recruiting, 22 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 48 completed trials in AZ Sint-Lucas, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Sint-Lucas, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 8 trials that are defined as “Not Applicable".